A diversity of novel type-2 innate lymphoid cell subpopulations revealed during tumour expansion

Type 2 innate lymphoid cells (ILC2s) perform vital functions in orchestrating humoral immune responses, facilitating tissue remodelling, and ensuring tissue homeostasis. Additionally, in a role that has garnered considerably less attention, ILC2s can also enhance Th1-related cytolytic T lymphocyte i...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Communications biology 2024-01, Vol.7 (1), p.12-12, Article 12
Hauptverfasser: Xia, Clara Wenjing, Saranchova, Iryna, Finkel, Pablo L., Besoiu, Stephanie, Munro, Lonna, Pfeifer, Cheryl G., Haegert, Anne, Lin, Yen-Yi, Le Bihan, Stéphane, Collins, Colin, Jefferies, Wilfred A.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Type 2 innate lymphoid cells (ILC2s) perform vital functions in orchestrating humoral immune responses, facilitating tissue remodelling, and ensuring tissue homeostasis. Additionally, in a role that has garnered considerably less attention, ILC2s can also enhance Th1-related cytolytic T lymphocyte immune responses against tumours. Studies have thus far generally failed to address the mystery of how one ILC2 cell-type can participate in a multiplicity of functions. Here we utilized single cell RNA sequencing analysis to create the first comprehensive atlas of naïve and tumour-associated lung ILC2s and discover multiple unique subtypes of ILC2s equipped with developmental gene programs that become skewed during tumour expansion favouring inflammation, antigen processing, immunological memory and Th1-related anti-tumour CTL responses. The discovery of these new subtypes of ILC2s challenges current paradigms of ILC2 biology and provides an explanation for their diversity of function. A study reveals that unique subtypes of innate lymphoid cells (ILC2s) contribute to diverse functions 53 such as tissue remodeling, immune responses, and anti-tumor CTL responses, challenging current 54 understandings of ILC2 biology.
ISSN:2399-3642
2399-3642
DOI:10.1038/s42003-023-05536-0